Retinitis Pigmentosa Clinical Trials

San Francisco : University of California, San Francisco

Retinal Imaging of Subjects Implanted With Ciliary Neurotrophic Factor (CNTF)-Releasing Encapsulated Cell Implant for Early-stage Retinitis Pigmentosa

West Orange : Kessler Institute for Rehabilitation

Combination Therapy With Dalfampridine and Locomotor Training for Chronic, Motor Incomplete Spinal Cord Injury

Portland : Casey Eye Institute

Study of UshStat in Patients With Retinitis Pigmentosa Associated With Usher Syndrome Type 1B

Montreal : Montreal Children's Hospital, McGill University Health Centre

Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01)

Aachen : RWTH University Eye Clinic

Argus® II Retinal Prosthesis System Post-Market Surveillance Study

Dresden : Helmut Sachs, MD, PD

Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients

Frankfurt-Hoechst : Claus Eckardt, MD, Prof.

Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients

Karlsruhe : Augenklinik des Staedtischen Klinikums

Argus® II Retinal Prosthesis System Post-Market Surveillance Study

Kiel : Johann Roider, MD, Prof.

Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients

View More »

Koln : Center for Ophthalmology - University of Koln

Argus® II Retinal Prosthesis System Post-Market Surveillance Study

Munich : Klinikum rechts der Isar - Technical University

Argus® II Retinal Prosthesis System Post-Market Surveillance Study

Tuebingen : Karl-Ulrich Bartz-Schmidt, MD, Prof.

Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients

Hong Kong : Ophthalmology Eye Institute, University of Hong Kong

Safety & Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients

Budapest : Miklos Resch, MD, PhD

Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients

Dublin : Royal Victoria Eye and Ear Hospital

Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65)

Pisa : University of Pisa Eye Surgery Department

Argus® II Retinal Prosthesis System Post-Market Surveillance Study

Pisa : Stanislao Rizzo, MD

Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients

Zurich : University Hospital Balgrist- Uniklinik Balgrist, Forschstrasse 340

Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Patients With Thoracic Spinal Cord Injury

London : Timothy L Jackson, MB.ChB, PhD, FRCOphth

Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients

Oxford : Robert MacLaren, MD, Prof., DPhil DipEd FRCOphth FRCS

Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients